Hepatocellular carcinoma

Current Opinion in Gastroenterology

Volumn 18, Issue 3, 2002, Pages 345-350

  Huang, Mary Ann ^a   Marrero, Jorge A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; INTERFERON;

CANCER SCREENING; CANCER SURVIVAL; CLINICAL TRIAL; DOPPLER ECHOGRAPHY; GENE EXPRESSION; GENE IDENTIFICATION; HEPATITIS B; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CODING; REVIEW;

EID: 0036224017     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200205000-00008     Document Type: Review

References (36)

1. Epidemiology of primary liver cancer
2. Rising incidence of hepatocellular carcinoma in the United States
3. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States
4. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease
5. Peanut butter intake, GSTM1 genotype and hepatocellular carcinoma: A case control study in Sudan
6. Hepatocellular carcinoma
7. The role of diabetes in hepatocellular carcinoma: A case-control study among United States veterans
8. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis
9. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with noncirrhotic and cirrhotic chronic viral hepatitis
10. Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation
11. Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw
12. Discrimination value of the new western prognostic system for hepatocellular carcinoma in 662 Japanese patients
13. Epidemiologic approach for cancer screening: Problems in design and analysis of trials
14. Surveillance program of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: A cost effectiveness analysis
15. Screening for hepatocellular carcinoma
16. Clinical management of hepatocellular carcinoma: Conclusions of the Barcelona-2000 EASL Conference
17. Frequent genomic imbalances suggest commonly altered tumor genes in human hepatocarcinogenesis
18. β-catenin mutation and overexpression in hepatocellular carcinoma: Clinicopathologic and prognostic significance
19. Expression profiling and identification of novel genes in hepatocellular carcinomas
20. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: Identification of genes involved in viral carcinogenesis and tumor progression
21. Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling
22. Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: Biologic and therapeutic implications
23. Liver cancer
24. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis
25. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: Prospective diagnosis with MR imaging and explantation correlation
26. Detection of malignant hepatic tumors: Comparison of gadolinium- and ferumoxide-enhanced MR imaging
27. Laparoscopy with laparoscopic ultrasound for pretreatment staging of hepatocellular carcinoma: A prospective study
28. Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis
29. Improving survival results after resection of hepatocellular carcinoma: A prospective study of 377 patients over 10 years
30. Liver transplantation for hepatocellular carcinoma
31. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors
32. Experience with radiofrequency ablation of small hepatocellular carcinomas before liver transplantation
33. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy
34. Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization
35. A phase II trial of oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinoma
36. Effects of long-term postoperative interferon-a therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma: A randomized, controlled trial